Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study.
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Inadequate antimicrobial treatment is an independent determinant of hospital mortality, and fungal bloodstream infections are among the types of infection with the highest rates of inappropriate initial treatment. Because of significant potential for reducing high mortality rates, we sought to assess the impact of delayed treatment across multiple study sites. The goals our analyses were to establish the frequency and duration of delayed antifungal treatment and to evaluate the relationship between treatment delay and mortality. METHODS: We conducted a retrospective cohort study of patients with candidemia from 4 medical centers who were prescribed fluconazole. Time to initiation of fluconazole therapy was calculated by subtracting the date on which fluconazole therapy was initiated from the culture date of the first blood sample positive for yeast. RESULTS: A total of 230 patients (51% male; mean age +/- standard deviation, 56 +/- 17 years) were identified; 192 of these had not been given prior treatment with fluconazole. Patients most commonly had nonsurgical hospital admission (162 patients [70%]) with a central line catheter (193 [84%]), diabetes (68 [30%]), or cancer (54 [24%]). Candida species causing infection included Candida albicans (129 patients [56%]), Candida glabrata (38 [16%]), Candida parapsilosis (25 [11%]), or Candida tropicalis (15 [7%]). The number of days to the initiation of antifungal treatment was 0 (92 patients [40%]), 1 (38 [17%]), 2 (33 [14%]) or > or = 3 (29 [12%]). Mortality rates were lowest for patients who began therapy on day 0 (14 patients [15%]) followed by patients who began on day 1 (9 [24%]), day 2 (12 [37%]), or day > or = 3 (12 [41%]) (P = .0009 for trend). Multivariate logistic regression was used to calculate independent predictors of mortality, which include increased time until fluconazole initiation (odds ratio, 1.42; P < .05) and Acute Physiology and Chronic Health Evaluation II score (1-point increments; odds ratio, 1.13; P < .05). CONCLUSION: A delay in the initiation of fluconazole therapy in hospitalized patients with candidemia significantly impacted mortality. New methods to avoid delays in appropriate antifungal therapy, such as rapid diagnostic tests or identification of unique risk factors, are needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The mortality reduction associated with early antimicrobials appears strongest in patients with septic shock, where studies have reported a strong association between time to antibiotics and death in patients with septic shock but weaker associations in patients without septic shock (98,109,110).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [109]
In the citing paper
“Blood cultures take an average of 2–3 days to grow Candida, or longer depending on the species.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [135]
In the citing paper
“Attributable mortality from IC remains high and increases with delays in treatment.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [135]
In the citing paper
“Some observational studies suggested that prompt initiation of appropriate empiric antifungal therapy may be associated with a reduction in mortality, however these studies do not prove a causal relationship between antifungal therapy and outcome, nor do they clarify the role of timing of treatment, and some other studies have failed to show this association [167, 171–173].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [171]
In the citing paper
“Multivariate analysis in this study also provided a strong association between delay in therapy and mortality.”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [46]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 11×
“By contrast, gram-positive bacteria, such as coagulase-negative staphylococci, S. aureus, and Enterococcus species, account for 60% of all BSIs [16].”
BackgroundInfluentialIbrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 2×
“of inappropriate initial treatment [6].”
BackgroundMorrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286 · cited 5×
“Delaying antifungal therapy appears to be a common practice, and the impact on mortality may be significant [8, 10].”
BackgroundResultInfluentialAttributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140 · cited 2×
“Attributable mortality rates of 49% were also shown among patients with candidemia, compared with uninfected control subjects matched for age, sex, date of hospital admission, underlying diseases, length of time at risk, and type of surgical procedure [5].”
BackgroundPfaller, M. A., Diekema, D. J., Jones, R. N., Sader, H. S., Fluit, A. C., Hollis, R. J., Messer, S. A., & The SENTRY Participant Group (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.9.3254-3259.2001 · Cited by 521 · cited 1×
“[1].”
Morgan, J., Meltzer, M. I., Plikaytis, B. D., Sofair, A. N., Huie-White, S., Wilcox, S., Harrison, L. H., Seaberg, E. C., Hajjeh, R. A., & Teutsch, S. M. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502581 · Cited by 437 · cited 2×
“attributable mortality remains 19%–49% [2, 5].”
Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00240-x · Cited by 331 · cited 10×
“By contrast, gram-positive bacteria, such as coagulase-negative staphylococci, S. aureus, and Enterococcus species, account for 60% of all BSIs [16].”
BackgroundInfluentialThe Impact of Candidemia on Length of Hospital Stay, Outcome, and Overall Cost of Illness
Rentz, A. M., Halpern, M. T., & Bowden, R. (1998) · Clinical Infectious Diseases · doi:10.1086/514955 · Cited by 310 · cited 1×
“of 8 cases per 100,000 population [2–4].”
Leinberger, D. M., Schumacher, U., Autenrieth, I. B., & Bachmann, T. T. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.4943-4953.2005 · Cited by 155 · cited 1×
“Development of nonculture methods for the rapid diagnosis of candidemia in patients with BSI may also significantly improve the ability to quickly prescribe appropriate antifungal therapy [19, 20].”
Epidemiology and Prognostic Determinants of Bloodstream Infections in Surgical Intensive Care
Harbarth, S. (2002) · Archives of Surgery · doi:10.1001/archsurg.137.12.1353 · Cited by 135
Cited by
Items 801–900 of 1,000
Chalin, A., Arvor, A., Hervault, A.-S., Plaisance, M., Niol, L., Simon, S., & Volland, H. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1439273 · Cited by 6
Tashiro, M., Takazono, T., Ota, Y., Wakamura, T., Takahashi, A., Sato, K., Miyazaki, T., Obata, Y., Nishino, T., & Izumikawa, K. (2021) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2021.06.013 · Cited by 6
A Case of Candidemia after Long-term Presence of Urethral Foreign Bodies
Nagata, J., Kawasaki, T., Iesato, K., Sugiura, T., Yamauchi, K., Tsuyusaki, J., Fujimura, M., Kuroda, F., Mikami, K., Dudek, S. M., et al. (2021) · IDCases · doi:10.1016/j.idcr.2021.e01176 · Cited by 7
Laroche, L., Mercier, V., & Sasso, M. (2022) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2022.115863 · Cited by 6
Non-superficial Cutaneous Manifestations by Candida Species
Figueroa-Ramos, G., Bermúdez‐Rodríguez, S. P., Gatica‐Torres, M., Barrera‐Godínez, A., Bonifáz, A., & Domínguez‐Cherit, J. (2024) · Current Fungal Infection Reports · doi:10.1007/s12281-024-00485-5 · Cited by 6
“Fortunately, the incidence of acute disseminated candidiasis in neutropenic patients has decreased since the introduction of fluconazole prophylaxis in 1990 [51].”
Opciones terapéuticas para el tratamiento antifúngico en el paciente crítico
Zaragoza, R., & Pemán, J. (2012) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2012.03.009 · Cited by 10
The Role of Conventional Diagnostic Tools
Verweij, P. E., van der Lee, H. A. L., & Rijs, A. J. M. M. (2007) · CRC Press eBooks · doi:10.3109/9781420017182.002 · Cited by 8
Bal, A. M. (2020) · Mycoses · doi:10.1111/myc.13196 · Cited by 6
Candida Infections in Solid Organ Transplantation
Barros, N., & Mansour, M. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-25869-6_43 · Cited by 7
Shukla, M., Chandley, P., Kaur, H., Ghosh, A. K., Rudramurthy, S. M., & Rohatgi, S. (2021) · Journal of Fungi · doi:10.3390/jof7120999 · Cited by 7
“Studies have shown that late and incorrect diagnosis of Candida species leads to a significant increase in mortality [20,21].”
ResultWiederhold, N. P., & Herrera, L. A. (2012) · Clinical Medicine Insights Pediatrics · doi:10.4137/cmped.s8016 · Cited by 7
Gupta, S., & Goyal, R. K. (2017) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-1601025761 · Cited by 6
Armaganidis, A., Nanas, S., Antoniadou, E., Mandragos, K. E., Liakou, K., Koutsoukou, A., Baltopoulos, G. J., Nakos, G., Kounougeri, A., Ganas, K., et al. (2017) · Mycoses · doi:10.1111/myc.12616 · Cited by 7
van Engen, A., Casamayor, M., Kim, S., Watt, M., & Odeyemi, I. A. O. (2017) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s141548 · Cited by 6
“Prompt and appropriate treatment of invasive Candida infection is critical, as a delay can prolong hospitalization 6,45 and is associated with a significant increase in mortality per day of inappropriate treatment.”
Li, M.-C., Chang, T. C., Chen, H.-M., Wu, C.-J., Su, S.-L., Lee, S. S. J., Chen, P., Lee, N., Lee, C., Li, C., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00051 · Cited by 7
“Since a delay in the initiation of antifungal therapy for candidemia increases the risk of mortality (Garey et al., 2006), timely antifungal therapy for the treatment of candidiasis is essential.”
BackgroundHas the Optimal Therapy for Invasive Candidiasis Now Been Defined?
Andes, D. R. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy830 · Cited by 6
Lam, S. W., & Bass, S. N. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190019831162 · Cited by 6
Prevention and Management of Complications
Kanodia, A., Verma, H., Jain, A., Kalsotra, G., Kumari, S., Agrawal, S. K., Gautam, H., Kaushal, D., Gugliani, A., & Lodha, J. (2021) · Springer eBooks · doi:10.1007/978-981-33-6284-0_8 · Cited by 9
Roth, R. S., Masouridi‐Levrat, S., Giannotti, F., Mamez, A., Glampedakis, E., Lamoth, F., Bochud, P., Erard, V., Emonet, S., van Delden, C., et al. (2021) · Mycoses · doi:10.1111/myc.13416 · Cited by 6
Merdan, O., Şişman, A. S., Aksoy, S. A., Kızıl, S., Tüzemen, N. Ü., Yılmaz, E., & Ener, B. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00776-22 · Cited by 7
Infectious Disease Emergencies
Nicolasora, N. P., & Kaul, D. R. (2008) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.10.006 · Cited by 6
Tavares, E. R., Santos, V. P., de Castro, I. M., Borges, P. H. G., Silva-Rodrigues, G., Olak, A. P. S., Bartolomeu-Gonçalves, G., Santos, J. P., Morey, A. T., Ishida, K., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199411 · Cited by 5
“Studies have shown that in-patients subjected to a delayed fluconazole treatment following the onset of the initial signs are more likely to experience fatal outcomes [1].”
InfluentialManagement of invasive candidiasis in nonneutropenic ICU patients
Weiss, E., & Timsit, J. (2014) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936114562586 · Cited by 7
“Several retrospective studies showed that time from first Candida-positive blood culture to initiation of antifungal therapy correlates with mortality increase [Garey et al. 2006; Morrell et al. 2005].”
BackgroundTheodore, D., Henneman, A. D., Loo, A. S., Shields, R. K., Eschenauer, G. A., Sobieszczyk, M. E., & Kubin, C. J. (2024) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae175 · Cited by 5
Caniff, K. E., Musawa, M. A., Judd, C., Shupp, M., Veve, M. P., Alangaden, G. J., Claeys, K. C., Scipione, M. R., Walsh, T. J., & Rybak, M. J. (2025) · Journal of Clinical Microbiology · doi:10.1128/jcm.00043-25 · Cited by 5
“Previous literature suggests that early initiation of antifungal therapy is associated with reduced mortality in patients with candidemia (16, 17).”
Fluconazole-Resistant Candida : Collateral Damage Associated with Prior Antibacterial Exposure?
Ben‐Ami, R., & Giladi, M. (2012) · Future Microbiology · doi:10.2217/fmb.12.83 · Cited by 6
Pharmacoeconomics of antifungal therapy: current considerations
Ashley, E. D. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000399604.68268.79 · Cited by 6
Lee, N., & Kym, D. (2021) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2021.02.004 · Cited by 5
Recomendaciones para el manejo de la candidemia en adultos en América Latina
Nucci, M., Thompson-Moya, L., Guzmán-Blanco, M., Tiraboschi, I. N., Cortés, J. A., Echevarria, J. I., Sifuentes‐Osornio, J., Zurita, J., Santolaya, M. E., Matute, T. A., et al. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.06.001 · Cited by 8
Knoll, M. A., Samardzic, E., Posch, W., & Lass‐Flörl, C. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00168-22 · Cited by 5
“Early and adequate antifungal treatment is crucial for patient survival in invasive candidiasis (1), and despite advances in modern medicine and diagnostics, therapeutic failure in”
BackgroundZou, Z.-Y., Sun, K.-J., Fu, G., Huang, J.-J., Yang, Z.-J., Zhou, Z.-P., Ma, S., Zhu, F., & Wu, M. T. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1047889 · Cited by 6
“Although prompt initiation of appropriate empiric antifungal treatment theoretically reduces mortality, there is disagreement between studies (Morrell et al., 2005; Garey et al., 2006; Marriott et al., 2009; Kollef et al., 2012).”
BackgroundZacharioudakis, I. M., Zervou, F. N., Marsh, K. L., Siegfried, J., Yang, J. Z., Decano, A., Dubrovskaya, Y., Mazo, D., & Aguero‐Rosenfeld, M. E. (2023) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2023.116107 · Cited by 5
Terminal-stage prognostic analysis in candidemia
Takuma, T., Shoji, H., & Niki, Y. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.01.007 · Cited by 5
Antifungal Drug Resistance: Clinical Relevance and Impact of Antifungal Drug Use
Drew, R. H., & Townsend, M. L. (2010) · Current Fungal Infection Reports · doi:10.1007/s12281-010-0013-y · Cited by 5
Does the current treatment of invasive fungal infection need to be reviewed?
Martín‐Peña, A., Aguilar‐Guisado, M., & Cisneros, J. M. (2013) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2013.02.008 · Cited by 7
Antimicrobial Stewardship Management of Infections: Beyond the Costs of Antimicrobials
Goff, D. A., Bauer, K. A. A., & Mangino, J. E. (2012) · Cited by 6
Steuber, T. D., Tucker-Heard, G., Edwards, J. D., Sawyer, A., Thottacherry, E. D., & Hassoun, A. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115086 · Cited by 5
Salehi, M., Ghaderkhani, S., Sharifian, R. A., Manshadi, S. A. D., Fard, E. S., Khodavaisy, S., Pourahmad, R., Foroushani, A. R., Rodini, K., & Sarvestani, H. K. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.803600 · Cited by 5
Boonstra, J., van der Elst, K. C. M., Zijlstra, J. G., van der Werf, T. S., Alffenaar, J. C., & Touw, D. J. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01113-22 · Cited by 5
Assessment of antifungal effect of omeprazole on Candida Albicans
kaslan, F. K. C. U. (2013) · International Journal for Biotechnology and Molecular Biology Research · doi:10.5897/ijbmbr2013.0157 · Cited by 5
“In particular, yeasts (such as Candida spp.) are the most frequently isolated fungi from human infections as well as dermatophytes (Banerjee et al., 2009; Fleischhacker et al., 2008; Garey et al., 2006).”
BackgroundOkinaka, K. (2016) · Medical Mycology Journal · doi:10.3314/mmj.16.003 · Cited by 5
Issues in the design and interpretation of antifungal drug trials in the critically ill
Ostrosky-Zeichner, L. L. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328331fc5f · Cited by 6
Usefulness of direct fluorescent in buffy coat in the diagnosis of Candida sepsis in neonates
Higareda-Almaraz, M. A., Loza-Barajas, H., Maldonado-González, J. G., Higareda-Almaraz, E., Benítez-Godínez, V., & Murillo‐Zamora, E. (2016) · Journal of Perinatology · doi:10.1038/jp.2016.96 · Cited by 5
When Diagnostic Technology Is Ahead of the Hospital Budget: What Is Antimicrobial Stewardship to Do?
Bauer, K. A. A., & Goff, D. A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ355 · Cited by 5
Clinical Utility of the T2Candida Panel: A Real-World Analysis of More Than 2000 Cases
Lötsch, F., Bouvier-Azula, L., Barousch, W., Camp, I., Starzengrüber, P., Makristathis, A., & Willinger, B. (2025) · Mycopathologia · doi:10.1007/s11046-025-00979-x · Cited by 4
“These approaches promise to offer a more rapid and more sensitive diagnosis of invasive candidiasis, which is crucial given that early initiation of antifungal therapy has the potential to reduce mortality [3].”
Verma, N., Valsan, A., Garg, P., Sarabu, S., Kaur, P., Mohan, N., De, A., Premkumar, M., Taneja, S., Prinja, S., et al. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003832 · Cited by 4
Zaragoza, R., Llinares, P., Maseda, E., Ferrer, R., & Rodríguez, A. H. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.005 · Cited by 4
Prevention and Management of Central Line-Associated Bloodstream Infections in Hospital Practice
Liang, S. Y., Khair, H., Durkin, M. J., & Marschall, J. (2012) · Hospital Practice · doi:10.3810/hp.2012.02.951 · Cited by 4
Keck, J. M., Cretella, D. A., Stover, K. R., Wagner, J. L., Barber, K. E., Jhaveri, T. A., Vijayvargiya, P., Garrigos, Z. E., & Wingler, M. J. B. (2023) · Antibiotics · doi:10.3390/antibiotics12020193 · Cited by 4
Experimental study of specific and nonspecific blood culture bottles for the diagnosis of candidemia
Wilot, L. C., Poester, V. R., Severo, C. B., Sanchotene, K. O., Esperon, B. M., Trápaga, M. R., Stevens, D. A., & Xavier, M. O. (2024) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2024.06.001 · Cited by 4
Empiric/pre-emptive anti-Candida therapy in non-neutropenic ICU patients
Timsit, J., Chemam, S., & Bailly, S. (2015) · F1000Prime Reports · doi:10.12703/p7-21 · Cited by 6
Early diagnosis of blood culture isolates in patients with candidemia using PNA FISH
Forrest, G. N. (2008) · Current Fungal Infection Reports · doi:10.1007/s12281-008-0032-0 · Cited by 4
Current Epidemiology and Management of Invasive Candidiasis in Infants
Zimmerman, K. O., & Smith, P. B. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0167-5 · Cited by 4
“Adult data suggests an incremental increase in mortality for each day of delayed initiation of antifungal therapy, from 15% on the day of culture positivity to 40 % on or after day 3 [96].”
BackgroundThe Effect of Intravenous Gamma-globulin Reagents on the Measurement Results of (1→3)-β-D-glucan
Moro, H., Koshio, N., Bamba, Y., Koizumi, T., Cho, H., Aoki, N., Hayashi, M., Tsubata, C., SAKAGAMI, A., Sato, M., et al. (2017) · Kansenshogaku zasshi · doi:10.11150/kansenshogakuzasshi.91.1 · Cited by 4
Hasan, M. J., Neelotpol, S., & Rabbani, R. (2022) · The Journal of Critical Care Medicine · doi:10.2478/jccm-2022-0006 · Cited by 4
“Some studies illustrated that early appropriate antifungal therapies reduce the rate of mortality with improved clinical outcomes in critically ill patients [1, 13, 14].”
BackgroundManagement of invasive fungal infections in the pediatric intensive care unit
Fisher, B. T., Zaoutis, T. E., & Chiotos, K. (2015) · Journal of Pediatric Intensive Care · doi:10.3233/pic-14108 · Cited by 4
“Timely initiation of anti-fungal therapy in patients with invasive candidal infections has been shown to improve outcomes in several retrospective studies, though prompt diagnosis of candidal infections is challenging in practice [34–36].”
BackgroundLaderas, J. C. P., & Pontes-Moreno, Y. A. (2011) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2011.06.004 · Cited by 4
Invasive Candidiasis in the Neutropenic Cancer Patient
Gamaletsou, M. N., Sipsas, N. V., & Kontoyiannis, D. P. (2010) · Current Fungal Infection Reports · doi:10.1007/s12281-010-0044-4 · Cited by 6
“Prior studies have shown that delays in treatment are associated with increased mortality in patients with candidemia [21].”
BackgroundEnfermedades invasivas por hongos levaduriformes en pacientes quemados graves
Escrig, A. I. R., García‐Vidal, C., & Salavert, M. (2016) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2016.02.002 · Cited by 4
Update on the Diagnosis of Candidemia and Invasive Candidiasis
González-Lara, M. F., & Ostrosky-Zeichner, L. L. (2019) · Current Fungal Infection Reports · doi:10.1007/s12281-019-00367-1 · Cited by 5
Evidence for the Application of Sepsis Bundles in 2021
Plata-Menchaca, E. P., Ruiz‐Rodríguez, J. C., & Ferrer, R. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1733899 · Cited by 4
Jain, N., Jansone, I., Obidenova, T., Sīmanis, R., Meisters, J., Straupmane, D., & Reinis, A. (2021) · Life · doi:10.3390/life11101002 · Cited by 6
Significance of immunotherapy for human fungal diseases and antifungal drug discovery
Mir, M. A., Jan, U., & Qadri, H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-96127-1.00001-2 · Cited by 5
Candida Infectious Endocarditis and Implantable Cardiac Device Infections
Fuller, R., & Jacobs, S. E. (2023) · Mycopathologia · doi:10.1007/s11046-023-00745-x · Cited by 4
Alsalman, J., Althaqafi, A., Alsaeed, A., Subhi, A., Mady, A. F., Alhejazi, A. Y., Francis, B., Alturkistani, H., Ayas, M. F., Bilbisi, M., et al. (2024) · Cureus · doi:10.7759/cureus.61127 · Cited by 5
“The timely detection and initiation of effective antifungal treatment are directly associated with enhanced survival in cases of fungal diseases [23].”
BackgroundBiomarkers for Diagnosis of Candidal Infections
Nguyen, M. H., & Clancy, C. J. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-011-0080-8 · Cited by 4
“Early administration of antifungal therapy improves outcomes of patients with invasive candidiasis, but clinicians face major challenges in making timely diagnoses [1, 2].”
BackgroundInvasive fungal infections: past achievements and challenges ahead
Arendrup, M. C. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02914.x · Cited by 6
“Yet still a number of infections go undiagnosed [16] or are diagnosed at a late stage, with a consequently poorer outcome [17,18].”
BackgroundThe “De-escalation Concept” and Antibiotic De-escalation: A Missed Opportunity?
Camargo, L. F. A. (2013) · Shock · doi:10.1097/shk.0b013e31828faf02 · Cited by 5
“In fungal infections, some studies have demonstrated that the timing of antifungal prescription could alter mortality rates, with more timely treatments reducing mortality rates (5).”
BackgroundCandida bloodstream infection: A clinical microbiology laboratory perspective
Pongrácz, J., & Kristóf, K. (2014) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/amicr.61.2014.3.11 · Cited by 4
“Furthermore, mortality is increased greatly by the delay of antifungal therapy (from 10–15% if treatment was started on the day of blood culture to 35–40% if treatment was started 3 days later) [13, 14].”
BackgroundArnould, J.-S., & Floch, R. L. (2015) · PubMed · Cited by 4
Candida albicans: Clinical Relevance, Pathogenesis, and Host Immunity
Correia, A., Sampaio, P., Vilanova, M., & Pais, C. (2015) · Wiley eBooks · doi:10.1002/9781118644843.ch50 · Cited by 5
Invasive candidiasis in critically ill patients
Kaaniche, F. M., Allela, R., Cherif, S., & Algia, N. B. (2016) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.tacc.2016.11.002 · Cited by 7
Opportunistic and systemic fungi
Mitchell, T. G., Verweij, P. E., & Hoepelman, A. I. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-04579-7.00178-7 · Cited by 4
Colombo, A. L., Guimarães, T., Camargo, L. F. A., Richtmann, R., Queiroz‐Telles, F., Salles, M. J. C., da Cunha, C. A., Shikanai‐Yasuda, M. A., Moretti, M. L., & Nucci, M. (2012) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(12)70336-7 · Cited by 6
Diagnosis and Management of Invasive Candida Infections in Critically Ill Patients
Zakhem, A. E., Istambouli, R., Jabbour, J.-F., Hindy, J.-R., Gharamti, A. A., & Kanj, S. S. (2022) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1741009 · Cited by 4
Reitler, P., DeJarnette, C. A., Kumar, R., Tucker, K. M., Peters, T. L., Twarog, N. R., Shelat, A. A., & Palmer, G. E. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00484-25 · Cited by 4
“reduce patient mortality (20, 21).”
Musculoskeletal Manifestations of Disseminated Fungal Infections
Koul, A., Traversone, J., Light, J. J., Chaturvedi, S., Daniel, J. M., & Rosenbaum, A. J. (2025) · JBJS Open Access · doi:10.2106/jbjs.oa.25.00095 · Cited by 3
Omics and Multiomics-Based Diagnostics for Invasive Candidiasis: Toward Precision Medicine
Pitarch, A., Arribas, V., & Gil, C. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101463 · Cited by 3
“Early diagnosis of IC (including candidemia and deep-seated candidiasis) is essential for a favorable clinical outcome, as its detection within the first 24 h is associated with a lower mortality risk (11–13).”
Yıldırmak, T., Gedık, H., Şimşek, F., İris, N., & Gücüyener, A. (2014) · West Indian Medical Journal · doi:10.7727/wimj.2012.140 · Cited by 3
“21 Fluconazole resistance (14, 14) 5 (11) 9 (16) 0.”
BackgroundEvolution in the Management of Invasive Fungal Infections in Liver Transplant Recipients
Verma, A., Weigel, K., Dexter, S. Y. K., & Dhawan, A. (2018) · OBM Transplantation · doi:10.21926/obm.transplant.1802009 · Cited by 3
Maximizing the diagnostic potential of 1,3 beta-D-glucan assays for invasive fungal infections
Morjaria, S. M., & Babady, N. E. (2025) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2025.01.001 · Cited by 3
Mattsby‐Baltzer, I., Pinel, C., Marcos, J. Y., Kondori, N., Potton, L., Thiébaut, A., Pelloux, H., & Cornet, M. (2015) · Medical Mycology · doi:10.1093/mmy/myv037 · Cited by 4
Fungal Infections in Cancer Patients
Granwehr, B. P., & Kontoyiannis, D. P. (2021) · Springer eBooks · doi:10.1007/978-3-319-74698-2_121-2 · Cited by 4
Clinical Surveillance of Candidemia at Our Hospital
Sano, A., Nishi, Y., Yonetani, S., Yoshida, H., Kawai, H., Homma, S., Araki, K., Ida, Y., Makino, H., Kurai, D., et al. (2021) · Medical Mycology Journal · doi:10.3314/mmj.20-00013 · Cited by 3
Ostrowski, J., Paterson, D. L., Lipman, J., & Udy, A. A. (2012) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1204000509 · Cited by 3
Chow, B. L., Groeschel, M., Carson, J. A., Griener, T. P., & Church, D. L. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07356-9 · Cited by 3
“Delayed diagnosis is associated with poor clinical outcomes because appropriate treatment measures are not promptly started [1, 11, 12].”
BackgroundTatsuta, K., Taki, Y., Nakatani, E., Higashizono, K., Nagai, E., Nishida, M., Sato, S., Ohata, K., Watanabe, M., Kanemoto, H., et al. (2022) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2021.893 · Cited by 3
Wen, H., Wang, W., Xie, S., Sun, Q., Liang, Y., Wen, B., Liu, Y., Sun, L., Zhang, Z., Cao, J., et al. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s358675 · Cited by 3
Matzko, M. E., Sephton-Clark, P., Young, E. L., Jhaveri, T. A., Martinsen, M. A., Mojica, E., Boykin, R., Pierce, V., Cuomo, C. A., & Bhattacharyya, R. P. (2022) · Medical Mycology · doi:10.1093/mmy/myac065 · Cited by 3
Post Covid-19 Sinonasal Candidiasis: A Crisis Within the Pandemic
Bhandari, S., Agarwal, S., Bhargava, S., Samdhani, S., Singh, S. N., Sharma, B. B., Malhotra, B., Bagarhatta, M., Sharma, S., Vyas, A., et al. (2022) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-022-03318-4 · Cited by 5
“In fact, a delay of 1–2 days in initiation of effective antifungal therapy has been associated with a doubling of mortality [28, 29].”
BackgroundLeitliniengerechte Therapie: Candidämie/invasive Candidiasis
Glöckner, A. (2010) · Mycoses · doi:10.1111/j.1439-0507.2009.01838.x · Cited by 7
Analytical Reviews: Antifungal Therapies in the Intensive Care Unit
Chowdhry, R., & Marshall, W. L. (2008) · Journal of Intensive Care Medicine · doi:10.1177/0885066607313000 · Cited by 5
Ağırbaşlı, H., Otlu, B., Bilgen, H., Durmaz, R., & Gedikoğlu, G. (2007) · Infection · doi:10.1007/s15010-007-6246-1 · Cited by 3
“indicated that delay in the initiation of antifungal therapy in hospitalized patients with candidemia significantly impacted mortality [17].”
BackgroundThe value of a risk model for early-onset candidemia
Sandrock, C., & Siddiqui, J. (2009) · Critical Care · doi:10.1186/cc8127 · Cited by 3
“In candidemia, studies have show that delayed therapy can lead to a higher mortality in hospitalized patients with late candidemia [11].”
BackgroundThe patient with candidemia: Treatment choices and algorithms
Pappas, P. G. (2008) · Current Fungal Infection Reports · doi:10.1007/s12281-008-0017-z · Cited by 3
Teixeira, H. M., Silva, L., Matias, C. D. N., Magalhães, J. F. F., Lyra, J. M. A., Magalhães, V., Melo, H. R. L., Jucá, M. B., & de Brito, C. A. A. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-014-2305-1 · Cited by 4
Detection of Candida albicans from Positive Blood Culture Bottles
Saad, U., Siddiqui, S., Jamil, N., Jamil, S., & Hafiz, S. (2013) · International Journal of Pathology · Cited by 3
Impact of New Diagnostic Approaches for Invasive Candidiasis on Antifungal Stewardship
Sofjan, A. K., Musgrove, R. J., & Garey, K. W. (2016) · Current Fungal Infection Reports · doi:10.1007/s12281-016-0257-2 · Cited by 3
Self-citationPerfect, J. R. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000399605.75891.fc · Cited by 4
Bretonnière, C., Lakhal, K., Lepoivre, T., Boutoille, D., & Morio, F. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.12.99 · Cited by 3
“Even uneasy to be definitely demonstrated, in ICU patients developing invasive candidiasis, a disease associated with a poor prognosis, delaying antifungal administration negatively impacts the outcome, as reported in several studies (2-4).”
Metadata
- Authors
- Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T.
- Affiliations
- University of Houston (US)
- University of New Mexico (US)
- Baptist Memorial Health Care (US)
- University of Tennessee Health Science Center (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Oregon State University (US)
- Corresponding author
- Garey, Kevin W.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-07
- Volume
- 43
- Issue
- 1
- Pages
- 25-31
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2164001967
- Semantic Scholar
- e1a67fd5e540307550577ea7a071370b075e943f
- Cited by
- 1,171
- References
- 20
- Citations by year
- 2026: 31 · 2025: 26 · 2024: 31 · 2023: 31 · 2022: 49 · 2021: 67 · 2020: 51 · 2019: 51 · 2018: 62 · 2017: 66 · 2016: 61 · 2015: 74 · 2014: 87 · 2013: 83 · 2012: 77
- FWCI
- 35.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Enzon Pharmaceuticals
- University of Houston
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, fluconazole, treatment delay, mortality, fungemia, Candida albicans, APACHE II score, mortality risk factors, hospitalized patients, Candida tropicalis, Candida parapsilosis, Candida glabrata, diabetes mellitus, cancer patients, sepsis
- MeSH terms
- Adult, Aged, Antifungal Agents, Candidiasis, Female, Humans, Length of Stay, Male, Middle Aged, Retrospective Studies, Time Factors, Cohort Studies, Fluconazole, Fungemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.